Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genous endothelial progenitor cell capturing stent vs. the Taxus Liberte stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study.
Beijk MA, Klomp M, Verouden NJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Scheunhage E, Piek JJ, Tijssen JG, de Winter RJ. Beijk MA, et al. Among authors: klomp m. Eur Heart J. 2010 May;31(9):1055-64. doi: 10.1093/eurheartj/ehp476. Epub 2009 Nov 18. Eur Heart J. 2010. PMID: 19933225 Free PMC article. Clinical Trial.
Twelve-month outcomes after coronary stenting with the Genous™ bio-engineered R Stent™ in diabetic patients from the e-HEALING registry.
Damman P, Klomp M, Beijk MA, Silber S, Grisold M, Ribeiro EE, Suryapranata H, Wójcik J, Sim KH, Tijssen JG, DE Winter RJ; e-HEALING Investigators. Damman P, et al. Among authors: klomp m. J Interv Cardiol. 2011 Aug;24(4):285-94. doi: 10.1111/j.1540-8183.2010.00624.x. Epub 2011 Jan 31. J Interv Cardiol. 2011. PMID: 21281358 Free article.
Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Beijk MA, Klomp M, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, Tijssen JG, Piek JJ, de Winter RJ. Beijk MA, et al. Among authors: klomp m. Catheter Cardiovasc Interv. 2011 Aug 1;78(2):189-95. doi: 10.1002/ccd.23143. Epub 2011 Jul 15. Catheter Cardiovasc Interv. 2011. PMID: 21542109 Clinical Trial.
Duration of dual antiplatelet therapy and outcomes after coronary stenting with the Genous™ bio-engineered R stent™ in patients from the e-HEALING registry.
Damman P, Klomp M, Silber S, Beijk MA, Ribeiro EE, Suryapranata H, Wójcik J, Sim KH, Tijssen JG, de Winter RJ; e-Healing investigators. Damman P, et al. Among authors: klomp m. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):243-52. doi: 10.1002/ccd.23156. Epub 2011 Dec 8. Catheter Cardiovasc Interv. 2012. PMID: 21542121 Clinical Trial.
Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.
Klomp M, Damman P, Beijk MA, Silber S, Grisold M, Ribeiro EE, Suryapranata H, Wòjcik J, Sim KH, Tijssen JG, de Winter RJ; e-HEALING investigators. Klomp M, et al. Heart Vessels. 2012 Jul;27(4):360-9. doi: 10.1007/s00380-011-0167-8. Epub 2011 Jul 2. Heart Vessels. 2012. PMID: 21725668
1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents.
Klomp M, Beijk MA, Varma C, Koolen JJ, Teiger E, Richardt G, Bea F, van Geloven N, Verouden NJ, Chan YK, Woudstra P, Damman P, Tijssen JG, de Winter RJ. Klomp M, et al. JACC Cardiovasc Interv. 2011 Aug;4(8):896-904. doi: 10.1016/j.jcin.2011.05.011. JACC Cardiovasc Interv. 2011. PMID: 21851905 Free article. Clinical Trial.
54 results